首页 › 黄斑变性 › 加利福尼亚州 › Sacramento
Sacramento CA 黄斑变性临床试验
8项针对 黄斑变性的研究正在 Sacramento及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
招募中2/3 期
- Retinal Consultants Medical Group (Site 020), Sacramento
- Retinal Consultants Medical Group (Site 022), Sacramento
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
招募中3 期
- UC Davis Health Eye Center, Sacramento
- Vrmg Inc, Sacramento
- Retinal Consultants Medical Group (RCMG) - Greenback Lane Retina Center, Sacramento
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
招募中2 期
- Retinal Consultants Medical Group, Sacramento
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
招募中观察性研究
- University of California Health - UC Davis, Sacramento
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
招募中1/2 期
- Retinal Consultants Medical Group, Sacramento
Phase 1 Study of C.001 in Retinal Degeneration
招募中1 期
- Retinal Consultants Medical Group, Sacramento
Effects of Goji vs. Fiber on Macular Degeneration
招募中欢迎健康志愿者
- UC Davis Eye Center, Tschannen Eye Institute, Sacramento
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
招募中3 期
- Retinal Consultants Medical Group Inc., Sacramento
- Retinal Consultants Medical Group, Sacramento
其他城市的 黄斑变性试验
- Dallas, TX13 项研究
- Erie, PA10 项研究
- The Woodlands, TX9 项研究
- Reno, NV8 项研究
- Hagerstown, MD8 项研究
- Fort Worth, TX7 项研究
- Cleveland, OH7 项研究
- Houston, TX7 项研究
- Austin, TX7 项研究
- Salt Lake City, UT7 项研究
- Carmel, IN7 项研究
- Phoenix, AZ7 项研究
Sacramento的其他研究
- 非小细胞肺癌29 项研究
- 肺癌22 项研究
- 乳腺癌20 项研究
- 前列腺癌19 项研究
- 转移性癌症16 项研究
- 急性髓系白血病12 项研究
- 心力衰竭12 项研究
- 胰腺癌12 项研究
- 癌症（所有类型）11 项研究
- 结肠癌11 项研究
- 膀胱癌10 项研究
- 结直肠癌10 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。